FDA MoCRA Requirements for Perfume Brands

What U.S. perfume brands need to know about MoCRA—registration, listing, adverse events, and safety records.

What MoCRA changed for cosmetics in the U.S.

The Modernization of Cosmetics Regulation Act (MoCRA), enacted in late 2022, expanded FDA authority over cosmetics—including perfume sold as cosmetic products. MoCRA is not a fragrance-specific law, but perfume brands are subject to its facility, listing, safety, and adverse event rules.

MoCRA does not replace IFRA industry standards or EU cosmetic rules if you export. Think of it as the U.S. baseline for responsible persons marketing cosmetic products domestically.

Facility registration and product listing

Responsible persons must register facilities that manufacture or process cosmetic products for U.S. distribution and list products with FDA. Many private label brands are the responsible person even when an overseas partner fills the product.

Confirm whether your manufacturer’s U.S. entity handles any registration on your behalf—most brands still need clarity on who lists the product under their brand name.

Serious adverse event reporting

MoCRA requires serious adverse event reports to FDA within 15 business days, with follow-up records. Train customer service to escalate rash, hospitalization, or similar reports—not only “smells weak” complaints.

Maintain complaint logs tied to batch or lot codes printed on packaging.

Safety substantiation and records

Brands must maintain evidence that products are safe under labeled conditions of use. For fragrance, that typically includes IFRA conformity, supplier safety assessments, stability data, and batch COAs archived by lot.

MoCRA grants FDA access to safety and manufacturing records during inspections—disorganized files become compliance risk.

Labeling and responsible person contact

U.S. cosmetic labeling still requires product identity, net quantity, ingredient declaration, and responsible person name and address. MoCRA reinforced record-keeping around labeling accuracy.

Fragrance allergens are not labeled in the EU Annex III style in the U.S. at the time of writing, but ingredient transparency rules differ by market—do not assume one label works globally without review.

Practical steps for private label founders

Before scaling U.S. sales: confirm responsible person role, register and list products per current FDA timelines, collect batch documentation from your manufacturer, and document safety rationale for your formula and format.

Work with a U.S. regulatory advisor for your specific entity structure—especially if you import finished goods or sell through large retailers with vendor compliance portals.

Is perfume a cosmetic under FDA rules?

Generally yes when sold for scent on the body. Different rules may apply to air care or non-cosmetic claims—product classification depends on intended use and claims.

Does IFRA compliance satisfy MoCRA?

IFRA supports safety substantiation but does not replace MoCRA registration, listing, labeling, or adverse event obligations.

Do small brands get exemptions?

MoCRA includes limited small-business exemptions for certain requirements, but adverse event reporting and safety substantiation still apply broadly. Confirm eligibility with a qualified advisor.

Quality and Compliance · FDA MoCRA requirements perfume brands

FDA MoCRA Requirements for Perfume Brands

What U.S. perfume brands need to know about MoCRA—registration, listing, adverse events, and safety records.

11 min read · By Brandsamor Editorial Team, Private label fragrance specialists

Published 2026-01-15 · Updated 2026-07-06

Reviewed by Brandsamor team

Sources: www.fda.gov

What MoCRA changed for cosmetics in the U.S.

The Modernization of Cosmetics Regulation Act (MoCRA), enacted in late 2022, expanded FDA authority over cosmetics—including perfume sold as cosmetic products. MoCRA is not a fragrance-specific law, but perfume brands are subject to its facility, listing, safety, and adverse event rules.

MoCRA does not replace IFRA industry standards or EU cosmetic rules if you export. Think of it as the U.S. baseline for responsible persons marketing cosmetic products domestically.

Facility registration and product listing

Responsible persons must register facilities that manufacture or process cosmetic products for U.S. distribution and list products with FDA. Many private label brands are the responsible person even when an overseas partner fills the product.

Confirm whether your manufacturer’s U.S. entity handles any registration on your behalf—most brands still need clarity on who lists the product under their brand name.

Serious adverse event reporting

MoCRA requires serious adverse event reports to FDA within 15 business days, with follow-up records. Train customer service to escalate rash, hospitalization, or similar reports—not only “smells weak” complaints.

Maintain complaint logs tied to batch or lot codes printed on packaging.

Safety substantiation and records

Brands must maintain evidence that products are safe under labeled conditions of use. For fragrance, that typically includes IFRA conformity, supplier safety assessments, stability data, and batch COAs archived by lot.

MoCRA grants FDA access to safety and manufacturing records during inspections—disorganized files become compliance risk.

Labeling and responsible person contact

U.S. cosmetic labeling still requires product identity, net quantity, ingredient declaration, and responsible person name and address. MoCRA reinforced record-keeping around labeling accuracy.

Fragrance allergens are not labeled in the EU Annex III style in the U.S. at the time of writing, but ingredient transparency rules differ by market—do not assume one label works globally without review.

Practical steps for private label founders

Before scaling U.S. sales: confirm responsible person role, register and list products per current FDA timelines, collect batch documentation from your manufacturer, and document safety rationale for your formula and format.

Work with a U.S. regulatory advisor for your specific entity structure—especially if you import finished goods or sell through large retailers with vendor compliance portals.

Frequently asked questions

Is perfume a cosmetic under FDA rules?
Generally yes when sold for scent on the body. Different rules may apply to air care or non-cosmetic claims—product classification depends on intended use and claims.
Does IFRA compliance satisfy MoCRA?
IFRA supports safety substantiation but does not replace MoCRA registration, listing, labeling, or adverse event obligations.
Do small brands get exemptions?
MoCRA includes limited small-business exemptions for certain requirements, but adverse event reporting and safety substantiation still apply broadly. Confirm eligibility with a qualified advisor.

Related commercial pages